サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1320243

レンチウイルスベクターCDMO（医薬品開発製造受託機関）市場：コンポーネント別、疾患適応別、エンドユーザー別、国別、地域別-業界分析、市場規模、市場シェア、2023年～2030年予測

Lentiviral Vector Contract Development & Manufacturing Organizations Market with COVID-19 Impact Analysis, By Component, Disease Indication, End User, Country, & Region-Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 359 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.70円
レンチウイルスベクターCDMO（医薬品開発製造受託機関）市場：コンポーネント別、疾患適応別、エンドユーザー別、国別、地域別-業界分析、市場規模、市場シェア、2023年～2030年予測
出版日: 2023年07月01日
発行: AnalystView Market Insights
ページ情報: 英文 359 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

レンチウイルスベクターCDMO（医薬品開発製造受託機関）市場規模は2022年に1億5,220万米ドルとなり、2023年から2030年にかけてCAGR 6.2%で拡大

レンチウイルスベクターCDMO市場-市場力学：

細胞治療と遺伝子治療への重点の高まりが、レンチウイルスベクターCDMOの需要を促進すると予想される

がん、希少遺伝子異常、自己免疫疾患など、数多くの遺伝性疾患や後天性疾患が、遺伝子治療や細胞治療による治療で大きな可能性を示しています。治療用遺伝子を標的細胞に送達するために不可欠なリソースであるレンチウイルスベクターのニーズは、より多くの可能性のある治療標的が発見され、検証されるにつれて高まると予想されます。生体外遺伝子編集と改変細胞治療は、レンチウイルスベクターの適応性と汎用性を利用した治療用途のほんの一例に過ぎないです。新しい治療法や個別化医療戦略の研究により、レンチウイルスベクターを使用するCDMOの需要が高まっています。

さらに、遺伝子治療や細胞治療の開発は、欧州医薬品庁（EMA）や米国食品医薬品局（FDA）のような規制機関から支援を受けています。このような新規医薬品の研究と販売を支援するために、迅速な規制手続きやその他のインセンティブが提供されているため、信頼できるレンチウイルスベクター製造パートナーの必要性が高まっています。

レンチウイルスベクターCDMO市場-主な洞察：

  • レンチウイルスベクターCDMO業界は、製造業への注目の高まりにより、大きな成長率で成長すると予測されます。
  • 疾患適応別では、がんセグメントが2022年に最大の市場シェアを示すと予測されました。
  • エンドユーザー別では、製薬・バイオテクノロジーセグメントが2030年までに大きな市場シェアを占めると予測されています。
  • コンポーネント別では、レンチウイルスプロモーターセグメントが2022年にリードしています。
  • 地域別では、北米が2022年の売上高をリードしています。

レンチウイルスベクターCDMO市場-セグメンテーション分析：

世界のレンチウイルスベクターCDMO市場は、コンポーネント、疾患適応、エンドユーザー、地域に基づいてセグメント化されます。

レンチウイルスプロモーター、レンチウイルス融合タグ、レンチウイルスパッケージングシステム、その他。レンチウイルスプロモーターセグメントが市場を独占しています。医療分野からのレンチウイルス受託開発需要の増加が市場開発に寄与しています。

市場は疾患適応別に5つのカテゴリーに分類される：がん、遺伝性疾患、感染症、動物の病気、その他。がんセグメントは市場を独占しています。がんとそのほかの疾患の有病率の増加が市場成長を後押しすると期待されています。

市場はエンドユーザーによって、製薬・バイオテクノロジー、学術研究、その他の3つに分類されます。製薬・バイオテクノロジーセグメントが市場を独占しています。製薬分野での医療開発需要の高まりが、同セグメントの成長を高めています。

レンチウイルスベクターCDMO市場-地理的洞察：

地理的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。

レンチウイルスベクターCDMO市場-競合情勢：

レンチウイルスベクターCDMO市場は、医療分野の急速な発展や製薬分野からの需要の高まりが影響しています。企業が参入を固め、市場シェアを拡大するために用いる主な手法や戦略には、新製品の発売、研究開発費、流通網の開発、M&Aなどがあります。最近の動向の一部を以下に紹介します。

最近の動き

2021年、Oxford BiomedicaはBoehringer Ingelheimとウイルスベクターの製造・供給に関する3年間の開発・供給契約を新たに締結しました。

目次

第1章 レンチウイルスベクターCDMO市場概要

  • 調査範囲

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 レンチウイルスベクターCDMOの主要な市場動向

  • レンチウイルスベクターCDMO市場促進要因
  • レンチウイルスベクターCDMO市場抑制要因
  • レンチウイルスベクターCDMO市場機会
  • レンチウイルスベクターCDMO市場の将来動向

第4章 レンチウイルスベクターCDMO業界調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 レンチウイルスベクターCDMO市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19以後の影響分析

第6章 レンチウイルスベクターCDMO市場情勢

  • レンチウイルスベクターCDMO市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 確立された企業の分析
    • 新興企業の分析

第7章 レンチウイルスベクターCDMO市場- コンポーネント別

  • 概要
    • コンポーネント別、セグメントシェア分析
    • レンチウイルスプロモーター
    • レンチウイルス融合タグ
    • レンチウイルスパッケージングシステム
    • その他

第8章 レンチウイルスベクターCDMO市場- 疾患適応別

  • 概要
    • 疾患適応別、セグメントシェア分析
    • がん
    • 遺伝的疾患
    • 感染症
    • 動物の病気
    • その他

第9章 レンチウイルスベクターCDMO市場- エンドユーザー別

  • 概要
    • エンドユーザー別、セグメントシェア分析
    • 製薬・バイオテクノロジー
    • 学術研究
    • その他

第10章 レンチウイルスベクターCDMO市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • 主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • 主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- レンチウイルスベクターCDMO業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Thermo Fisher Scientific Inc.
    • Oxford Biomedica
    • Charles River Laboratories International, Inc.
    • Creative Biogene
    • GenScript ProBio
    • Merck KGaA
    • Catalent Inc.
    • Ask Bio
    • Lonza
    • Curia Global, Inc.
    • Wuxi Advanced Therapies
    • SIRION Biotech GmbH
    • VGXI, Inc.
    • Yposkesi
    • Oxford Genetics Ltd.

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Lentiviral Vector Contract Development and Manufacturing Organizations Market: Component Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Component
  • TABLE Global Lentiviral Vector Contract Development and Manufacturing Organizations Market, by Component 2018-2030 (USD Million)
  • TABLE Lentiviral Vector Contract Development and Manufacturing Organizations Market: Disease Indication Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Disease Indication
  • TABLE Global Lentiviral Vector Contract Development and Manufacturing Organizations Market, by Disease Indication 2018-2030 (USD Million)
  • TABLE Lentiviral Vector Contract Development and Manufacturing Organizations Market: Regional snapshot (2022)
  • TABLE Lentiviral Vector Contract Development and Manufacturing Organizations Market: End User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Lentiviral Vector Contract Development and Manufacturing Organizations Market, by End User 2018-2030 (USD Million)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Lentiviral Vector Contract Development and Manufacturing Organizations Market, by Region 2018-2030 (USD Million)
  • TABLE North America Lentiviral Vector Contract Development and Manufacturing Organizations Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Lentiviral Vector Contract Development and Manufacturing Organizations Market, by Component, 2018-2030 (USD Million)
  • TABLE North America Lentiviral Vector Contract Development and Manufacturing Organizations Market, by Disease Indication, 2018-2030 (USD Million)
  • TABLE North America Lentiviral Vector Contract Development and Manufacturing Organizations Market, by End User, 2018-2030 (USD Million)
  • TABLE Europe Lentiviral Vector Contract Development and Manufacturing Organizations Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Lentiviral Vector Contract Development and Manufacturing Organizations Market, by Component, 2018-2030 (USD Million)
  • TABLE Europe Lentiviral Vector Contract Development and Manufacturing Organizations Market, by Disease Indication, 2018-2030 (USD Million)
  • TABLE Europe Lentiviral Vector Contract Development and Manufacturing Organizations Market, by End User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Lentiviral Vector Contract Development and Manufacturing Organizations Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Lentiviral Vector Contract Development and Manufacturing Organizations Market, by Component, 2018-2030 (USD Million)
  • TABLE Asia Pacific Lentiviral Vector Contract Development and Manufacturing Organizations Market, by Disease Indication, 2018-2030 (USD Million)
  • TABLE Asia Pacific Lentiviral Vector Contract Development and Manufacturing Organizations Market, by End User, 2018-2030 (USD Million)
  • TABLE Latin America Lentiviral Vector Contract Development and Manufacturing Organizations Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Lentiviral Vector Contract Development and Manufacturing Organizations Market, by Component, 2018-2030 (USD Million)
  • TABLE Latin America Lentiviral Vector Contract Development and Manufacturing Organizations Market, by Disease Indication, 2018-2030 (USD Million)
  • TABLE Latin America Lentiviral Vector Contract Development and Manufacturing Organizations Market, by End User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Lentiviral Vector Contract Development and Manufacturing Organizations Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Lentiviral Vector Contract Development and Manufacturing Organizations Market, by Component, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Lentiviral Vector Contract Development and Manufacturing Organizations Market, by Disease Indication, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Lentiviral Vector Contract Development and Manufacturing Organizations Market, by End User, 2018-2030 (USD Million)

List of Figures

  • FIGURE Lentiviral Vector Contract Development and Manufacturing Organizations Market Segmentation
  • FIGURE Market research Disease Indicationology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Component segment market share analysis, 2022 & 2030
  • FIGURE Component segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Disease Indication segment market share analysis, 2022 & 2030
  • FIGURE Disease Indication segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End User segment market share analysis, 2022 & 2030
  • FIGURE End User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Lentiviral Vector Contract Development and Manufacturing Organizations Market share and leading players, 2022
  • FIGURE Europe Lentiviral Vector Contract Development and Manufacturing Organizations Market share and leading players, 2022
  • FIGURE Asia Pacific Lentiviral Vector Contract Development and Manufacturing Organizations Market share and leading players, 2022
  • FIGURE Latin America Lentiviral Vector Contract Development and Manufacturing Organizations Market share and leading players, 2022
  • FIGURE Middle East and Africa Lentiviral Vector Contract Development and Manufacturing Organizations Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Lentiviral Vector Contract Development and Manufacturing Organizations Market share analysis by country, 2022
  • FIGURE Germany Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Lentiviral Vector Contract Development and Manufacturing Organizations Market share analysis by country, 2022
  • FIGURE India Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Lentiviral Vector Contract Development and Manufacturing Organizations Market share analysis by country, 2022
  • FIGURE Brazil Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Lentiviral Vector Contract Development and Manufacturing Organizations Market share analysis by country, 2022
  • FIGURE Saudi Arabia Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Lentiviral Vector Contract Development and Manufacturing Organizations Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1554

REPORT HIGHLIGHT

Lentiviral Vector Contract Development and Manufacturing Organizations Market size was valued at USD 152.2 Million in 2022, expanding at a CAGR of 6.2% from 2023 to 2030.

Contract Development and Manufacturing Organizations (CDMOs) are specialized in lentiviral vector production. These organizations offer services for the development, manufacturing, and production of lentiviral vectors for gene therapy, cell therapy, and other Disease Indications.

Lentiviral Vector Contract Development and Manufacturing Organizations Market- Market Dynamics:

Growing emphasis on cell and gene therapies is expected to propel the Lentiviral Vector Contract Development and Manufacturing Organizations demand.

Numerous hereditary and acquired diseases, such as cancer, rare genetic abnormalities, and autoimmune diseases, have showed great promise in the treatment with gene and cell treatments. The need for lentiviral vectors, which are essential resources for delivering therapeutic genes to target cells, is anticipated to rise as more possible therapeutic targets are discovered and verified. Ex vivo gene editing and modified cell treatments are just a couple of the therapeutic uses for lentiviral vectors' adaptability and versatility. The investigation of novel therapeutic modalities and individualized medical strategies has increased demand for CDMOs using lentiviral vectors.

Further, the development of gene and cell therapies has received support from regulatory organizations like the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA). The need for trustworthy lentiviral vector manufacturing partners has increased because of the quicker regulatory procedures and other incentives they have offered to support the research and marketing of these novel medicines.

Lentiviral Vector Contract Development and Manufacturing Organizations Market- Key Insights:

  • As per the analysis shared by our research analyst, the global Lentiviral Vector Contract Development and Manufacturing Organizations market is estimated to grow annually at a CAGR of around 6.2% over the forecast period (2023-2030)
  • The Lentiviral Vector Contract Development and Manufacturing Organizations industry is projected to grow at a significant rate due to the growing focus on manufacturing industries.
  • Based on Disease Indication, cancer segment was predicted to show maximum market share in the year 2022.
  • Based on End User, pharmaceutical & biotech segment is expected to hold significant market share by 2030.
  • Based on Component segmentation, lentiviral promoter segment was the leading in 2022
  • On the basis of region, North America was the leading revenue generator in 2022.

Lentiviral Vector Contract Development and Manufacturing Organizations Market- Segmentation Analysis:

The Global Lentiviral Vector Contract Development and Manufacturing Organizations Market is segmented on the basis of Component, Disease Indication, End User, and Region.

The market is divided into four categories based on Component: lentiviral promoter, lentiviral fusion tags, lentivirus packaging systems and others. The lentiviral promoter segment dominates the market. Increasing demand from medical sector for lentiviral contract developments is contributing to market growth.

The market is divided into five categories based on Disease Indication: cancer, genetic disorders, infectious diseases, veterinary disease, and others. The cancer segment dominates the market. Increasing prevalence of cancer and its other disease forms is expected to boost the market growth.

The market is divided into three categories based on End User: pharmaceutical & biotech, academic research, and others. The pharmaceutical & biotech segment dominates the market. The rising demand from medical development in pharma sector is increasing the segment growth.

Lentiviral Vector Contract Development and Manufacturing Organizations Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Lentiviral Vector Contract Development and Manufacturing Organizations Market- Competitive Landscape:

Owing to the fast development in medical, and rising demand from pharmaceutical sector, which influence the lentiviral vector contract development and manufacturing organizations market. Several companies promote their products, including corporate websites, and Disease Indications, are used by businesses to sell their solutions & Disease Indications. Composite manufacturers compete on various factors, such as composite pricing, performance, composite creation, and marketing. reputation, and availability. Some of the primary techniques, and strategies used by corporations to consolidate their reach and expand their market share include new product launches, R&D expenditure, developing its distribution network and mergers & acquisitions. Some of the recent developments are mentioned below.

Recent Developments:

In 2021, Oxford Biomedica signed a new three-year development and supply agreement with Boehringer Ingelheim to manufacture and supply viral vectors.

Key features of the study:

  • This proposed research study on Lentiviral Vector Contract Development and Manufacturing Organizations market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Lentiviral Vector Contract Development and Manufacturing Organizations market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Lentiviral Vector Contract Development and Manufacturing Organizations market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Lentiviral Vector Contract Development and Manufacturing Organizations market
  • Impact of COVID-19 on Lentiviral Vector Contract Development and Manufacturing Organizations market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Lentiviral Vector Contract Development and Manufacturing Organizations market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Lentiviral Vector Contract Development and Manufacturing Organizations market, we have also included competitive landscape and key innovator analysis for the Lentiviral Vector Contract Development and Manufacturing Organizations market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial inspection and strategic initiatives of players operating in the Lentiviral Vector Contract Development and Manufacturing Organizations market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Lentiviral Vector Contract Development and Manufacturing Organizations market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LENTIVIRAL VECTOR CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET KEY PLAYERS

  • Thermo Fisher Scientific Inc.
  • Oxford Biomedica
  • Charles River Laboratories International, Inc.
  • Creative Biogene
  • GenScript ProBio
  • Merck KGaA
  • Catalent Inc.
  • Ask Bio
  • Lonza
  • Curia Global, Inc.
  • Wuxi Advanced Therapies
  • SIRION Biotech GmbH
  • VGXI, Inc.
  • Yposkesi
  • Oxford Genetics Ltd.

GLOBAL LENTIVIRAL VECTOR CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET, BY COMPONENT

  • Lentiviral promoter
  • Lentiviral fusion tags
  • Lentivirus packaging systems
  • Others

GLOBAL LENTIVIRAL VECTOR CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET, BY DISEASE INDICATION

  • Cancer
  • Genetic disorders
  • Infectious diseases
  • Veterinary disease
  • Others

GLOBAL LENTIVIRAL VECTOR CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET, BY END USER

  • Pharmaceutical & biotech
  • Academic research
  • Others

GLOBAL LENTIVIRAL VECTOR CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Lentiviral Vector Contract Development and Manufacturing Organizations Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Lentiviral Vector Contract Development and Manufacturing Organizations Market Snippet by Component
    • 2.1.2. Lentiviral Vector Contract Development and Manufacturing Organizations Market Snippet by Disease Indication
    • 2.1.3. Lentiviral Vector Contract Development and Manufacturing Organizations Market Snippet by End User
    • 2.1.4. Lentiviral Vector Contract Development and Manufacturing Organizations Market Snippet by Country
    • 2.1.5. Lentiviral Vector Contract Development and Manufacturing Organizations Market Snippet by Region
  • 2.2. Competitive Insights

3. Lentiviral Vector Contract Development and Manufacturing Organizations Key Market Trends

  • 3.1. Lentiviral Vector Contract Development and Manufacturing Organizations Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Lentiviral Vector Contract Development and Manufacturing Organizations Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Lentiviral Vector Contract Development and Manufacturing Organizations Market Opportunities
  • 3.4. Lentiviral Vector Contract Development and Manufacturing Organizations Market Future Trends

4. Lentiviral Vector Contract Development and Manufacturing Organizations Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Lentiviral Vector Contract Development and Manufacturing Organizations Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Lentiviral Vector Contract Development and Manufacturing Organizations Market Landscape

  • 6.1. Lentiviral Vector Contract Development and Manufacturing Organizations Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Lentiviral Vector Contract Development and Manufacturing Organizations Market - By Component

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Component, 2022 & 2030 (%)
    • 7.1.2. Lentiviral promoter
    • 7.1.3. Lentiviral fusion tags
    • 7.1.4. Lentivirus packaging systems
    • 7.1.5. Others

8. Lentiviral Vector Contract Development and Manufacturing Organizations Market - By Disease Indication

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Disease Indication, 2022 & 2030 (%)
    • 8.1.2. Cancer
    • 8.1.3. Genetic disorders
    • 8.1.4. Infectious diseases
    • 8.1.5. Veterinary disease
    • 8.1.6. Others

9. Lentiviral Vector Contract Development and Manufacturing Organizations Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Disease Indication, 2022 & 2030 (%)
    • 9.1.2. Pharmaceutical & biotech
    • 9.1.3. Academic research
    • 9.1.4. Others

10. Lentiviral Vector Contract Development and Manufacturing Organizations Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Lentiviral Vector Contract Development and Manufacturing Organizations Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Lentiviral Vector Contract Development and Manufacturing Organizations Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Lentiviral Vector Contract Development and Manufacturing Organizations Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Lentiviral Vector Contract Development and Manufacturing Organizations Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Lentiviral Vector Contract Development and Manufacturing Organizations Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Component, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Disease Indication, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Lentiviral Vector Contract Development and Manufacturing Organizations Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Thermo Fisher Scientific Inc.
    • 11.2.2. Oxford Biomedica
    • 11.2.3. Charles River Laboratories International, Inc.
    • 11.2.4. Creative Biogene
    • 11.2.5. GenScript ProBio
    • 11.2.6. Merck KGaA
    • 11.2.7. Catalent Inc.
    • 11.2.8. Ask Bio
    • 11.2.9. Lonza
    • 11.2.10. Curia Global, Inc.
    • 11.2.11. Wuxi Advanced Therapies
    • 11.2.12. SIRION Biotech GmbH
    • 11.2.13. VGXI, Inc.
    • 11.2.14. Yposkesi
    • 11.2.15. Oxford Genetics Ltd.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Disease Indicationology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us